A pharmaceutical company preparing an electronic Common Technical Document (eCTD) submission for a regulatory authority identifies several technical deficiencies during final quality control review, including unreadable scanned documents, non-functional internal hyperlinks, restricted file access settings, and inconsistencies in document structure and navigation.Discuss the potential regulatory, technical validation, and operational consequences these deficiencies may have on the acceptance, review efficiency, and overall assessment of the submission if not corrected before submission.

Which combination correctly identifies;the provision in the Medicines and Related Substances Act,1965 (Act 101 of 1965) that enables the exclusion of certain compounded medicines from registration requirements; andthe regulation that prescribes the conditions applicable to such compounding activities?

Several protocol versions stored in the investigator site file are missing approval dates and signatures. In addition, staff members are uncertain which version of the protocol is currently approved for use at the site. Which of the following best reflects GCP requirements for essential records?

A pharmaceutical quality control laboratory is preparing to implement a new analytical method for testing the potency of a pharmaceutical product before routine batch release testing can begin. The laboratory manager emphasizes that several procedures must be completed to ensure compliance with Good Analytical Laboratory Practice and regulatory requirements. Which of the following combinations of procedures should be performed before the new analytical method is implemented for routine use?

A sponsor contracts an external electronic document management vendor to maintain portions of the trial master file during a multicentre clinical trial. Midway through the study, the vendor changes ownership and several records become temporarily inaccessible to monitors and investigators. Which of the following best describes the sponsor’s and investigator’s responsibilities under GCP?

A pharmaceutical quality control laboratory retains only printed chromatograms and PDF exports generated from its chromatography software. After results are reviewed and approved, analysts routinely delete the original electronic raw data files from the laboratory computer system. Why does this practice represent a serious data integrity risk in a regulated GxP environment?

A pharmacist at a community pharmacy compounds a customised oral suspension for a paediatric patient based on a valid prescription from a medical practitioner. The pharmacist is asked why the compounded product has not been registered with the South African Health Products Regulatory Authority (SAHPRA). The pharmacist explains that certain compounded medicines are specifically excluded from registration requirements under South African medicines legislation. Which legislative provision most specifically provides for this exemption?

Identify the statutory provision that empowers the development of Good Pharmacy Practice (GPP) standards in South Africa, and provide the official publication reference for the Rules Relating to Good Pharmacy Practice.

If I fall below 80% at any point during the course, I am encouraged to meet with the instructor for remediation.

Please type your full name and today’s date to serve as your acknowledgment of the syllabus.